Evommune

Acquisition, funding and merger involving Evommune.

• Evommune has just announced a $50 Million fundraising (posted on May 2 2023).

View the org chart displaying its 16 main executives

Most searched biographies at Evommune

• Luis Peña, Director, President & Chief Executive Officer
• Benjamin McGraw, Director
• Felice Verduyn-Van Weegen, Director

Create your alert
to follow the executive moves at Evommune.

Evommune has 2,288 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).
• Aardvark Therapeutics has just announced a $85 Million fundraising (posted on May 12 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Evommune

Social media about Evommune

• Evommune on Wikipedia, Google News & Yahoo Finance
• Evommune on LinkedIn, Twitter & YouTube

Contact by email its executives including Luis Peña

Call Evommune at +1 949...

View the org chart

Register to receive your alert

Report an error